Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon
D. G. Couch, Chris Tasker, Elena Theophilidou, et al.
Clinical Science (2017) Vol. 131, Iss. 21, pp. 2611-2626
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer
Federica Pellati, Vittoria Borgonetti, Virginia Brighenti, et al.
BioMed Research International (2018) Vol. 2018, pp. 1-15
Open Access | Times Cited: 312
Immune Responses Regulated by Cannabidiol
James M. Nichols, Barbara L.F. Kaplan
Cannabis and Cannabinoid Research (2019) Vol. 5, Iss. 1, pp. 12-31
Open Access | Times Cited: 235
Cannabidiol: pharmacology and therapeutic targets
Stevie C. Britch, Shanna Babalonis, Sharon Walsh
Psychopharmacology (2020) Vol. 238, Iss. 1, pp. 9-28
Open Access | Times Cited: 221
Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science
Eric P. Baron
Headache The Journal of Head and Face Pain (2018) Vol. 58, Iss. 7, pp. 1139-1186
Closed Access | Times Cited: 212
A systematic review of cannabidiol dosing in clinical populations
Sophie Millar, Nicole L. Stone, Z.D. Bellman, et al.
British Journal of Clinical Pharmacology (2019) Vol. 85, Iss. 9, pp. 1888-1900
Open Access | Times Cited: 197
Diversity of molecular targets and signaling pathways for CBD
Douglas Lamounier de Almeida, Lakshmi A. Devi
Pharmacology Research & Perspectives (2020) Vol. 8, Iss. 6
Open Access | Times Cited: 194
A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain
Christopher D. Verrico, Shonda Wesson, Vanaja Konduri, et al.
Pain (2020) Vol. 161, Iss. 9, pp. 2191-2202
Open Access | Times Cited: 147
The Polypharmacological Effects of Cannabidiol
Jorge Iván Castillo-Arellano, Ana Canseco-Alba, Stephen J. Cutler, et al.
Molecules (2023) Vol. 28, Iss. 7, pp. 3271-3271
Open Access | Times Cited: 71
An Overview of Cannabidiol as a Multifunctional Drug: Pharmacokinetics and Cellular Effects
Nadia Martínez Naya, Jazmin Kelly, Giuliana Corna, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 473-473
Open Access | Times Cited: 22
Cannabis sativa L. extract and cannabidiol inhibit in vitro mediators of skin inflammation and wound injury
Enrico Sangiovanni, Marco Fumagalli, Barbara Pacchetti, et al.
Phytotherapy Research (2019) Vol. 33, Iss. 8, pp. 2083-2093
Closed Access | Times Cited: 106
Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol
Patrícia Alves, Cristina Amaral, Natércia Teixeira, et al.
Pharmacological Research (2020) Vol. 157, pp. 104822-104822
Closed Access | Times Cited: 106
Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo—A Randomized, Placebo-controlled, Double-blind Controlled Trial
D. G. Couch, Hollie Cook, Catherine A. Ortori, et al.
Inflammatory Bowel Diseases (2019) Vol. 25, Iss. 6, pp. 1006-1018
Open Access | Times Cited: 88
The Expanded Endocannabinoid System/Endocannabinoidome as a Potential Target for Treating Diabetes Mellitus
Alain Veilleux, Vincenzo Di Marzo, Cristoforo Silvestri
Current Diabetes Reports (2019) Vol. 19, Iss. 11
Open Access | Times Cited: 78
Palmitoylethanolamide counteracts high-fat diet-induced gut dysfunction by reprogramming microbiota composition and affecting tryptophan metabolism
Claudio Pirozzi, Lorena Coretti, Nicola Opallo, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 22
The NLRP3 inflammasome: a vital player in inflammation and mediating the anti-inflammatory effect of CBD
Feng-xin Chu, Xiao Wang, Bo Li, et al.
Inflammation Research (2024) Vol. 73, Iss. 2, pp. 227-242
Closed Access | Times Cited: 12
Role of TRPV1 and TRPA1 Ion Channels in Inflammatory Bowel Diseases: Potential Therapeutic Targets?
Kata Csekő, Abraham B. Beckers, Dániel Keszthelyi, et al.
Pharmaceuticals (2019) Vol. 12, Iss. 2, pp. 48-48
Open Access | Times Cited: 69
Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases
Melanie Kienzl, Martin Storr, Rudolf Schicho
Clinical and Translational Gastroenterology (2020) Vol. 11, Iss. 1, pp. e00120-e00120
Open Access | Times Cited: 54
Biological effects of Cannabidiol on normal human healthy cell populations: Systematic review of the literature
Stefano Pagano, Maddalena Coniglio, Chiara Valenti, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 132, pp. 110728-110728
Open Access | Times Cited: 53
Cannabinoids and Inflammations of the Gut-Lung-Skin Barrier
Cristian Scheau, Constantin Căruntu, Ioana Anca Bădărău, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 6, pp. 494-494
Open Access | Times Cited: 49
Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies
Mariana Veiga, João Azevedo‐Silva, João Carlos Fernandes
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 155-155
Open Access | Times Cited: 17
The Use of Cannabinoids in Colitis: A Systematic Review and Meta-Analysis
D. G. Couch, Henry Maudslay, Brett Doleman, et al.
Inflammatory Bowel Diseases (2018) Vol. 24, Iss. 4, pp. 680-697
Open Access | Times Cited: 57
Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries: modification by hypertension and the potential pharmacological opportunities
Marta Baranowska‐Kuczko, Hanna Kozłowska, Monika Kloza, et al.
Journal of Hypertension (2019) Vol. 38, Iss. 5, pp. 896-911
Open Access | Times Cited: 49
Identification of Chemotypic Markers in Three Chemotype Categories of Cannabis Using Secondary Metabolites Profiled in Inflorescences, Leaves, Stem Bark, and Roots
Dan Jin, Philippe Henry, Jacqueline J. Shan, et al.
Frontiers in Plant Science (2021) Vol. 12
Open Access | Times Cited: 34
Biological effects of cannabidiol on human cancer cells: Systematic review of the literature
Chiara Valenti, Monia Billi, Gian Luca Pancrazi, et al.
Pharmacological Research (2022) Vol. 181, pp. 106267-106267
Closed Access | Times Cited: 24
Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations
Abdel-ilah Aziz, Long C. Nguyen, Loubna Oumeslakht, et al.
Cannabis and Cannabinoid Research (2022)
Closed Access | Times Cited: 23
Page 1 - Next Page

Scroll to top